Angion Biomedica (NASD: ANGN) CEO Focus on Primary Proteinuric Kidney Diseases

Interview with Jay Venkatesan, M.D., the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. (ANGN).

Related Keywords

Angion Biomedica ,Jay Venkatesan ,University Of Pennsylvania School Medicine ,Alpine Immune Sciences ,Boehringer Ingelheim ,Williams College ,Angion Biomedica Corp ,Patricof Co ,Mckinsey Co ,Wharton School Of The University Pennsylvania ,Primary Proteinuric Kidney ,Chief Executive Officer ,Managing Partner ,Bayer Capital ,Brookside Capital ,Bain Capital ,Apax Partners ,Pennsylvania School ,Wharton School ,Wall Street Transcript ,Wall Street ,